Influence of Chemokine Receptors on T Cell Cytokine Profiles in Skin
趋化因子受体对皮肤 T 细胞细胞因子谱的影响
基本信息
- 批准号:8225940
- 负责人:
- 金额:$ 20.55万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-03-01 至 2014-02-28
- 项目状态:已结题
- 来源:
- 关键词:AdjuvantAffectAgonistAntigensBiological AssayBloodCC chemokine receptor 4CCR6 geneCD4 Positive T LymphocytesCarbohydratesCellsCharacteristicsCholera ToxinCommitCutaneousE-SelectinEnvironmentGPR2 geneHomingIL17 geneImmuneImmune responseImmunizationImmunologyInflammationInflammatoryInterleukin-17LigandsLymphoidMediatingMemoryModelingMusOrganPatientsPlayPopulationProcessProductionPsoriasisReactionResearchRoleSignal TransductionSkinT cell responseT-LymphocyteTestingTissuesTopical applicationTransgenic OrganismsWorkbasecell mediated immune responsechemokine receptorcytokineexperienceimmune functionimprintin vivointerestlymph nodesmigrationnovelpreventreceptorresponsesingle moleculetraffickingtranscription factor
项目摘要
DESCRIPTION (provided by applicant): The subset of antigen-experienced CD4 T cells dedicated to skin immunology express the carbohydrate ligand for E-selectin (E-lig) along with chemokine receptor CCR4. We have developed an in vivo assay in which naive TCR-transgenic OT-II cells develop into skin-homing T cells in response to topically applied antigen. We have successfully used this assay to investigate the conditions required for naive cells to differentiate in to cutaneous memory cells, and to explore the role of CCR4 in the process by which T cells enter cutaneous tissue from the blood. Although CCR4-deficient OT-II cells are severely impaired in their ability to enter inflamed skin, they appear to replicate normally within the skin-draining lymph nodes (LN) in response to antigen. This assay employs an antigen/adjuvant combination that creates a psoriasis-like cytokine environment, generating populations of antigen-specific T cells that express IFN3 or IL17, but not common TH2-associated cytokines. CCR4-deficient T cells in this same assay did not produce IL-17, which we found to be the dominant cytokine produced by normal skin-imprinted E-lighi cells. Conversely, IFN3 expression was significantly increased for CCR4-deficient cells. To our knowledge, this is the first case in which the functional absence of a chemokine receptor has been observed to alter the TH cytokine profile of T cells responding to a given antigen. In this project, we propose to more fully explore this novel discovery, and test several hypotheses regarding the mechanism by which CCR4 ultimately influences the cytokine profile. We propose to assess expression of a wider variety of cytokines than those examined in our preliminary work to probe the full extent to which CCR4 influences this process. We will also look for differences in the expression of transcription factors associated with the various TH lineages. We will attempt to distinguish whether CCR4 influences the cytokine profile by guiding cells to a microenvironment within skin that is permissive for IL17 induction, or whether CCR4 signals directly influence TH imprinting. Furthermore, we will use various TLR ligands as adjuvants to alter the cytokine responses produced in our model, and assess the influence of CCR4 under these altered conditions. Finally, we will assess the ability of two other skin-associated chemokine receptors, CCR6 and CCR10, for their own potential to influence TH cytokine profiles in this assay.
PUBLIC HEALTH RELEVANCE: We have made the unexpected discovery that a class of molecules called chemokine receptors can alter the cytokine response against a given antigen. Chemokine receptors are mainly known for their role in directing the migration of immune cells around the body as they engage in surveillance for unwanted invaders. We believe that our new discovery will open up an entirely new direction of research on how to positively manipulate the type of immune response in which a patient engages.
描述(由申请人提供):专用于皮肤免疫学的抗原经验的CD4 T细胞的子集表达E-选择蛋白(E-LIG)的碳水化合物配体以及趋化因子受体CCR4。我们已经开发了一种体内测定,其中天真的TCR转基因OT-II细胞响应局部施用的抗原而形成皮肤染色的T细胞。我们已经成功地使用了该测定法来研究幼稚细胞与皮肤记忆细胞区分开所需的条件,并探索CCR4在T细胞从血液中进入皮肤组织的过程中的作用。尽管缺乏CCR4的OT-II细胞进入发炎的皮肤的能力严重受损,但它们似乎在响应抗原的响应于皮肤干燥的淋巴结(LN)中正常复制。该测定法采用抗原/辅助组合,产生牛皮癣样细胞因子环境,产生表达IFN3或IL17但不常见Th2相关的细胞因子的抗原特异性T细胞种群。该测定中的CCR4缺陷型T细胞没有产生IL-17,我们发现这是正常皮肤敏感的E-Lighi细胞产生的主要细胞因子。相反,对于CCR4缺陷型细胞,IFN3表达显着增加。据我们所知,这是观察到功能性缺乏趋化因子受体的第一种情况,可以改变对给定抗原反应的T细胞的TH细胞因子谱。在这个项目中,我们建议更全面地探索这一新颖的发现,并检验有关CCR4最终影响细胞因子概况的机制的几种假设。我们建议评估比初步工作中所检查的细胞因子的表达,以探测CCR4影响这一过程的全部程度。我们还将寻找与各种谱系相关的转录因子表达的差异。我们将尝试通过将细胞引导到皮肤中的微环境来区分CCR4是否会影响细胞因子的谱,该微环境允许IL17诱导,或者CCR4信号是否直接影响TH印迹。此外,我们将使用各种TLR配体作为佐剂来改变模型中产生的细胞因子反应,并评估CCR4在这些改变条件下的影响。最后,我们将评估另外两个与皮肤相关的趋化因子受体CCR6和CCR10的能力,以便在该测定中影响细胞因子谱的潜力。
公共卫生相关性:我们已经意外发现,一类称为趋化因子受体的分子可以改变针对给定抗原的细胞因子反应。趋化因子受体主要以指导体内免疫细胞迁移的作用,因为它们在进行不需要的入侵者的监视时。我们认为,我们的新发现将为如何积极操纵患者参与的免疫反应类型开辟一个全新的研究方向。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
James J. Campbell其他文献
James J. Campbell的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('James J. Campbell', 18)}}的其他基金
Chemokine Receptor CCR7 In Tissue-Specific T Cell Imprinting and Autoimmunity
组织特异性 T 细胞印迹和自身免疫中的趋化因子受体 CCR7
- 批准号:
8272537 - 财政年份:2011
- 资助金额:
$ 20.55万 - 项目类别:
Chemokine Receptor CCR7 In Tissue-Specific T Cell Imprinting and Autoimmunity
组织特异性 T 细胞印记和自身免疫中的趋化因子受体 CCR7
- 批准号:
8190270 - 财政年份:2011
- 资助金额:
$ 20.55万 - 项目类别:
Loading Skin-Derived Antigen on Dendritic Cells in Vivo for T Responses in Vitro
将皮肤源性抗原加载到体内树突状细胞上以实现体外 T 反应
- 批准号:
7707028 - 财政年份:2009
- 资助金额:
$ 20.55万 - 项目类别:
Loading Skin-Derived Antigen on Dendritic Cells in Vivo for T Responses in Vitro
将皮肤源性抗原加载到体内树突状细胞上以实现体外 T 反应
- 批准号:
7860362 - 财政年份:2009
- 资助金额:
$ 20.55万 - 项目类别:
The Role of CCR4 in Skin Lymphocyte Homing and Immunity
CCR4 在皮肤淋巴细胞归巢和免疫中的作用
- 批准号:
6755999 - 财政年份:2001
- 资助金额:
$ 20.55万 - 项目类别:
The Role of CCR4 in Skin Lymphocyte Homing and Immunity
CCR4 在皮肤淋巴细胞归巢和免疫中的作用
- 批准号:
6331894 - 财政年份:2001
- 资助金额:
$ 20.55万 - 项目类别:
The Role of CCR4 in Skin Lymphocyte Homing and Immunity
CCR4 在皮肤淋巴细胞归巢和免疫中的作用
- 批准号:
6611429 - 财政年份:2001
- 资助金额:
$ 20.55万 - 项目类别:
The Role of CCR4 in Skin Lymphocyte Homing and Immunity
CCR4 在皮肤淋巴细胞归巢和免疫中的作用
- 批准号:
6511204 - 财政年份:2001
- 资助金额:
$ 20.55万 - 项目类别:
The Role of CCR4 in Skin Lymphocyte Homing and Immunity
CCR4 在皮肤淋巴细胞归巢和免疫中的作用
- 批准号:
7741230 - 财政年份:2000
- 资助金额:
$ 20.55万 - 项目类别:
The Role of CCR4 in Skin Lymphocyte Homing and Immunity
CCR4 在皮肤淋巴细胞归巢和免疫中的作用
- 批准号:
7151962 - 财政年份:2000
- 资助金额:
$ 20.55万 - 项目类别:
相似国自然基金
β2AR激动剂与微秒电刺激对大鼠肛提肌线粒体有氧代谢酶及其多模态影像表型的影响研究
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
环境激素壬基酚对变应性鼻炎的影响及其对GPER特异性激动剂G-1在变应性鼻炎治疗作用中的干扰机制研究
- 批准号:82000963
- 批准年份:2020
- 资助金额:24 万元
- 项目类别:青年科学基金项目
促生长激素释放激素激动剂抑制平滑肌细胞转分化对动脉粥样硬化的影响及机制研究
- 批准号:81900389
- 批准年份:2019
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
五羟色胺2C受体激动剂对2型糖尿病小鼠β细胞功能的影响及机制研究
- 批准号:81803644
- 批准年份:2018
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
cAMP信号激动剂对恶性胶质瘤血管新生和血管正常化的影响及机制研究
- 批准号:81803568
- 批准年份:2018
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Novel first-in-class Therapeutics for Rheumatoid Arthritis
类风湿关节炎的一流新疗法
- 批准号:
10696749 - 财政年份:2023
- 资助金额:
$ 20.55万 - 项目类别:
A Novel Assay to Improve Translation in Analgesic Drug Development
改善镇痛药物开发转化的新方法
- 批准号:
10726834 - 财政年份:2023
- 资助金额:
$ 20.55万 - 项目类别:
A Novel Sublingual Vaccine to Prevent Neisseria Gonorrhoeae Infection
预防淋病奈瑟菌感染的新型舌下疫苗
- 批准号:
10699065 - 财政年份:2023
- 资助金额:
$ 20.55万 - 项目类别:
Molecular basis of activation of the orphan nuclear receptor Nurr1
孤儿核受体 Nurr1 激活的分子基础
- 批准号:
10831795 - 财政年份:2023
- 资助金额:
$ 20.55万 - 项目类别:
O-polysaccharide (OPS)-IpaB Conjugate Vaccine to Prevent Shigellosis
O-多糖 (OPS)-IpaB 结合疫苗预防志贺氏菌病
- 批准号:
10704815 - 财政年份:2023
- 资助金额:
$ 20.55万 - 项目类别: